Advertisement
Laekna, Inc.

Laekna, Inc. (2105.HK) Stock Overview

Explore Laekna, Inc.’s financial performance, market position, analyst ratings, and future outlook.

2105.HKHKSE
HealthcareBiotechnology
HK$6.22
HK$0.39(5.90%)
Hong Kong Market opens in 43h 37m
Advertisement

Laekna, Inc. (2105.HK)

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E RatioN/A
EPS (TTM)$-0.68
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$4.84
3 Months$0.00
1 Year Target$0.00

2105.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Laekna, Inc. (2105.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 19.03, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.90%
5-Day Change
-17.07%
1-Month Change
-53.23%
3-Month Change
-57.10%
6-Month Change
-54.10%
Year-to-Date (YTD) Change
-54.30%
1-Year Change
-64.50%
3-Year Change
-58.53%
5-Year Change
-58.53%
All-Time (Max) Change
-58.53%

Contact Information

NaN
3-2-467, 5 Xingbin Road, Yuyao, NaN, NaN

Company Facts

830 Employees
IPO DateJun 28, 2023
CountryCN
Actively Trading

Frequently Asked Questions